senior notes offering

The company plans to use the proceeds to repay loan and revolving credit facilities incurred to pay a portion of its 2017 acquisition of Euroimmun.

The firm has said that it intends to use the net proceeds and available cash to redeem its outstanding 5.25 percent senior notes due in 2022 in the amount of $1 billion.

Underwriter Merrill Lynch exercised in full the option to purchase up to an additional $90M in senior notes on top of a $600M notes offering announced last week.

The firm intends to use the net proceeds and available cash to redeem its outstanding 5.25 percent senior notes due 2022 in the amount of $1 billion.

With WHO prequalification, global health organizations can consider the Aptima HIV-1 Quant Dx for public-sector procurement in resource-limited countries.

The company said it will use the proceeds from the offering for general corporate and working capital purposes.

The firm intends to use the net proceeds of the offering and available cash to retire its remaining convertible notes when they become callable.

The firm said that it expects to use the proceeds of the senior notes offering to contribute to retirement of remaining convertible notes.

The firm said it intends to use net proceeds from the issuance of the notes for general corporate purposes.

The offering consists of two tranches of $600 million each, and the firm plans to use the net proceeds for general corporate purposes, including the repayment of outstanding senior notes due on Aug. 23. 

Pages

Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.

Human Heredity and Health in Africa Initiative has issued guidelines for genomic research in the region, according to Nature News.

The Associated Press reports that an ethicist predicts that prenatal diagnosis and other advances will lead to more choices being available to prospective parents.

In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.